lissamine rhodamine b has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, HK; Chung, KS; Im, JY; Jung, KE; Jung, YJ; Kim, BK; Kim, MH; Kim, YH; Kim, YJ; Lee, JS; Song, KB; Won, KJ; Won, M; Yun, CO | 1 |
| Jankovic, D; Kanazir, S; Markovic, ID; Markovic, JZ; Pesic, M; Rakic, L; Ruzdijic, S | 1 |
2 other study(ies) available for lissamine rhodamine b and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Human Noxin is an anti-apoptotic protein in response to DNA damage of A549 non-small cell lung carcinoma.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cells, Cultured; Comet Assay; DNA Damage; Flow Cytometry; Gene Expression Profiling; Humans; In Situ Hybridization; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rhodamines; RNA, Messenger; RNA, Small Interfering; Tumor Suppressor Protein p53; Ultraviolet Rays | 2014 |
Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Curcumin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione Transferase; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Paclitaxel; Rhodamines; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Verapamil; Vinblastine | 2006 |